We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 10,000 results
  1. Vaccination and Multiple Sclerosis – Current Situation

    Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown...

    A. N. Boyko, S. A. Sivertseva, ... M. E. Guseva in Neuroscience and Behavioral Physiology
    Article 01 May 2022
  2. Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis

    Background

    Immunoglobulin G4-related disease (IgG4-RD) and systemic sclerosis (SSc) are rare autoimmune diseases characterized by the presence of CD4+...

    Damian R. Plichta, Juhi Somani, ... Ramnik J. Xavier in Genome Medicine
    Article Open access 28 February 2021
  3. Autophagy in Multiple Sclerosis: Phagocytosis and Autophagy of Oligodendrocyte Precursor Cells

    Multiple sclerosis (MS) is a leading cause of chronic neurological dysfunction in young to middle-aged adults, affecting approximately 2.5 million...

    Jia-Qi Wang, Qiang Li, ... **ng Li in Molecular Neurobiology
    Article 16 February 2024
  4. Association between MEF2 family gene polymorphisms and susceptibility to multiple sclerosis in Chinese population

    Purpose

    Multiple sclerosis (MS) is an autoimmune disease characterized by inflammatory demyelinating lesions in the white matter of the central...

    Lei Wu, Bo Liu, ... Peng Lu in Acta Neurologica Belgica
    Article 12 August 2023
  5. Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis

    Background

    For the past three years, the pandemic has had a major effect on global public health, mainly on those with underlying medical conditions,...

    Seyedeh Sadigheh Hamzavi, Rosemina Bahrololoom, ... Marzieh Jamalidoust in BMC Immunology
    Article Open access 19 June 2024
  6. Excitotoxicity and Amyotrophic Lateral Sclerosis

    Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterized by the progressive and selective death of motor neurons...
    Kim A. Staats, Ludo Van Den Bosch in Handbook of Neurotoxicity
    Reference work entry 2022
  7. Tissue-resident immune cells in the pathogenesis of multiple sclerosis

    Background

    Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS) in which genetic and environmental...

    Jie Tian, Lingli Jiang, ... Ke Rui in Inflammation Research
    Article 22 December 2022
  8. Tyrosine Kinases: Targets for Epigenetic Influences and a New Direction in the Treatment of Multiple Sclerosis

    Studies have shown that tyrosine kinases (TK) may play an important role in the pathogenesis of multiple sclerosis (MS) operating through a microRNA...

    Article 01 March 2023
  9. The Search for Immunological Biomarkers in Type 1 Diabetes Mellitus (T1DM) and Multiple Sclerosis (MS): Th40 Cells Provide a Common Autoimmune Link

    Biomarkers to predict autoimmune disease onset or predict progression are sorely lacking. A specific T cell subset present in peripheral blood of...
    David H. Wagner in Biomarkers in Diabetes
    Reference work entry 2023
  10. Acupuncture Treatment for Multiple Sclerosis

    Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system, which affected millions of patients worldwide with no...
    Chapter 2022
  11. Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus

    Autoimmune diseases are caused by an imbalance in the immune system, producing autoantibodies that cause inflammation leading to tissue damage and...

    Shima Famil Samavati, Reza Yarani, ... Kamran Mansouri in Journal of Inflammation
    Article Open access 12 June 2024
  12. Immune responses following COVID-19 infection in multiple sclerosis patients using immunomodulatory therapy

    Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2), has quickly become a global...

    Nuray Bilge, Fatma Kesmez Can, Recep Yevgi in Acta Neurologica Belgica
    Article 04 November 2022
  13. A Drug–Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Microgynon (Ethinylestradiol and Levonorgestrel) in Female Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

    Background and Objectives

    Nintedanib is a tyrosine kinase inhibitor approved for the treatment of systemic sclerosis-associated interstitial lung...

    Madelon C. Vonk, Alfredo Guillén-Del-Castillo, ... Martina Gahlemann in European Journal of Drug Metabolism and Pharmacokinetics
    Article Open access 18 October 2021
  14. The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis

    Multiple sclerosis (MS) is a chronic condition affecting the central nervous system (CNS), where the interplay of genetic and environmental factors...

    Mohamed J. Saadh, Hani Moslem Ahmed, ... Nathera Hussin Alwan in NeuroMolecular Medicine
    Article 17 April 2024
  15. Infection-Induced Systemic Inflammation and Dementia

    It has long been recognized that there exists a unique interaction between the peripheral immune system and the brain, an interaction that is...
    Newman Osafo, Silvio Owusu Dei, ... Oduro Kofi Yeboah in Current Thoughts on Dementia
    Chapter 2022
  16. Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears

    Multiple sclerosis (MS) is an autoimmune demyelinating neurodegenerative disease of the central nervous system (CNS) due to injury of the myelin...

    Mubarak Alruwaili, Hayder M. Al-kuraishy, ... Gaber El-Saber Batiha in Neurochemical Research
    Article Open access 13 July 2023
  17. Roles and regulation of microglia activity in multiple sclerosis: insights from animal models

    As resident macrophages of the CNS, microglia are critical immune effectors of inflammatory lesions and associated neural dysfunctions. In multiple...

    Félix Distéfano-Gagné, Sara Bitarafan, ... David Gosselin in Nature Reviews Neuroscience
    Article 02 June 2023
  18. Involvement of gut microbiota in multiple sclerosis—review of a new pathophysiological hypothesis and potential treatment target

    Multiple sclerosis (MS) is a chronic inflammatory disease that leads to demyelination and damage to the central nervous system. It is well known, the...

    Piotr Olejnik, Kasper Buczma, ... Kaja Kasarełło in Immunologic Research
    Article 06 March 2024
  19. Broadening our understanding of genetic risk for scleroderma/systemic sclerosis by querying the chromatin architecture surrounding the risk haplotypes

    Background

    Genetic variants in the human leukocyte antigen (HLA) locus contribute to the risk for develo** scleroderma/systemic sclerosis (SSc)....

    Kerry E. Poppenberg, Vincent M. Tutino, ... James N. Jarvis in BMC Medical Genomics
    Article Open access 24 April 2021
  20. Sirtuins and Metabolism Biomarkers in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: a Correlation Study with Clinical Outcomes and Cognitive Impairments

    Multiple sclerosis (MS) is a primary inflammatory demyelinating disease with different clinical courses and subtypes. The present study aimed to...

    Forough Foolad, Zahra Samadi-Bahrami, ... Mohammad Javan in Molecular Neurobiology
    Article 23 November 2023
Did you find what you were looking for? Share feedback.